‌

US Patent 8790647 Treatment of vasculoproliferative conditions with Lrg1 anatgonists

Patent 8790647 was granted and assigned to UCL Business Ltd on July, 2014 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Current Assignee

UCL Business Ltd

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

8790647

Date of Patent

July 29, 2014

Patent Application Number

13393531

Date Filed

September 6, 2010

Patent Citations Received

‌

US Patent 12071476 IL-6 antibodies and fusion constructs and conjugates thereof

‌

US Patent 11686731 Prostate cancer markers and uses thereof

‌

US Patent 11692840 Device, method, and graphical user interface for synchronizing two or more displays

‌

US Patent 11912784 Methods of treating an eye disorder

Patent Primary Examiner

‌

Christine J. Saoud

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8790647 Treatment of vasculoproliferative conditions with Lrg1 anatgonists

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API